Taken together, these results indicated that CD14+CD16+ monocyte subpopulation was implicated in the pathogenesis of CHD patients with BSS, which may be one of the bases of the essence of BSS investigation. The gene discussed is FCGR3A; the disease is coronary artery disorder.